John Lee

Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986

Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY.

Part of UCB SA, Central Pharmaceuticals is an American pharmaceutical company. The company is located in the US. Central Pharmaceuticals was acquired by UCB Pharma GmbH, part of UCB SA from January 04, 2007 on June 01, 1995 for $172.29 million.

UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.